Revenue from operations increased to Rs 7,567 crore in the June quarter as against Rs 6,851 crore in the year-ago period, the drug maker said in a statement.
Survival Over Hype: The hidden trait that builds long-term wealth
Global markets face inflation and uncertainty. Veteran investor Thomas Russo suggests true company survivors possess a ‘capacity to suffer’. These businesses reinvest for future growth,